DSK Co., Ltd. (KOSDAQ:109740)
South Korea · Delayed Price · Currency is KRW 3,600.00
-100.00 (-2.70%)
At close: Oct 23, 2026
DSK Co., Ltd. Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 20,558 | 43,179 | 22,640 | 71,500 | 48,232 | 49,791 |
Revenue Growth | -51.84% | 90.72% | -68.34% | 48.24% | -3.13% | 52.79% |
Gross Profit Gross Profit Growth | -8,695 | -8,945 | -7,342 | 3,434 | -1,814 | 3,723 |
Operating Income Operating Income Growth | -22,633 | -22,722 | -19,700 | -9,707 | -13,124 | -6,344 |
Net Income Net Income Growth | -13,312 | -15,523 | -7,840 | 3,258 | -6,453 | -397.02 |
Earnings Per Share EPS Growth | -532.22 | -619.00 | -309.38 | 124.92 | -244.00 | -18.39 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceutical Manufacture Pharmaceutical Manufacture Growth | 3,502 | 2,059 | 3,662 | 4,781 | 2,312 | 594.07 |
Equipment Manufacturing Equipment Manufacturing Growth | 17,056 | 41,120 | 19,336 | 67,677 | 46,678 | 51,618 |
Internal Sales Internal Sales Growth | - | - | -358.35 | -958.31 | -757.36 | -2,421 |
Total Total Growth | 20,558 | 43,179 | 22,640 | 71,500 | 48,232 | 49,791 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 29,628 | 32,777 | 34,086 | 42,070 | 49,048 | 68,754 |
Total Debt Total Debt Growth | 23,565 | 23,609 | 13,836 | 13,302 | 13,318 | 8,364 |
Net Cash (Debt) Net Cash Growth | 6,064 | 9,168 | 20,250 | 28,768 | 35,730 | 60,390 |
Net Cash Growth | -60.72% | -54.73% | -29.61% | -19.48% | -40.84% | 780.37% |
Net Cash Per Share Net Cash Per Share Growth | 242.06 | 365.38 | 799.08 | 1103.08 | 1348.47 | 2797.54 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -11,481 | -10,711 | -8,439 | -10,328 | 634.96 | -3,538 |
Capital Expenditures CapEx Growth | -242.01 | -447.65 | -3,076 | -1,286 | -11,583 | -1,430 |
Free Cash Flow Free Cash Flow Growth | -11,723 | -11,159 | -11,515 | -11,614 | -10,948 | -4,968 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | -42.29% | -20.72% | -32.43% | 4.80% | -3.76% | 7.48% |
Operating Margin | -110.10% | -52.62% | -87.01% | -13.58% | -27.21% | -12.74% |
Pretax Margin | -82.11% | -45.95% | -52.63% | 5.84% | -19.47% | -8.97% |
Profit Margin | -64.76% | -35.95% | -34.63% | 4.56% | -13.38% | -0.80% |
FCF Margin | -57.03% | -25.84% | -50.86% | -16.24% | -22.70% | -9.98% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 40.81 | - | - |
PS Ratio | 4.39 | 4.13 | 4.94 | 1.86 | 2.77 | 4.01 |